Primary biliary cholangitis: a comprehensive overview
- 21 November 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Hepatology International
- Vol. 11 (6), 485-499
- https://doi.org/10.1007/s12072-017-9830-1
Abstract
Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by biliary destruction, progressive cholestasis, and potentially liver cirrhosis. Patients develop a well-orchestrated immune reaction, both innate and adaptive, against mitochondrial antigens that specifically targets intrahepatic biliary cells. A puzzling feature of PBC is that the immune attack is predominantly organ specific, although the mitochondrial autoantigens are found in all nucleated cells. The disease results from a combination of genetic and environmental risk factors; however, the exact pathogenesis remains unclear. Serologically, PBC is characterized by presence of antimitochondrial antibodies, which are present in 90–95 % of patients and are often detectable years before clinical signs appear. Like other complex disorders, PBC is heterogeneous in its presentation, symptomatology, disease progression, and response to therapy. A significant number of patients develop end-stage liver disease and eventually require liver transplantation. Recent studies from large international cohorts have better identified prognostic factors, suggesting a change in patient management based on risk stratification. Therapeutic options are changing. In this review we discuss data on the autoimmune responses and treatment of the disease.Keywords
This publication has 110 references indexed in Scilit:
- Distinct MicroRNAs Expression Profile in Primary Biliary Cirrhosis and Evaluation of miR 505-3p and miR197-3p as Novel BiomarkersPLOS ONE, 2013
- Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese PopulationAmerican Journal of Human Genetics, 2012
- Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosisNature Genetics, 2012
- Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosisGenes & Immunity, 2012
- Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosisHepatology, 2011
- Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosisNature Genetics, 2011
- Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosisNature Genetics, 2010
- Primary biliary cirrhosis is associated with altered hepatic microRNA expressionJournal of Autoimmunity, 2009
- Primary Biliary Cirrhosis Associated withHLA, IL12A,andIL12RB2VariantsThe New England Journal of Medicine, 2009
- Apotopes and the biliary specificity of primary biliary cirrhosisHepatology, 2009